Evelo Biosciences Inc (OTCPK:EVLO)
$ 0.06 0 (0%) Market Cap: 1.14 Mil Enterprise Value: 17.82 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 0/100

Evelo Biosciences Inc to Host Key Opinion Leader Symposium on Unmet Need in Mild to Moderate Psoriasis and Potential for EDP1815 Call Transcript

Oct 04, 2019 / 12:30PM GMT
Release Date Price: $120.8 (+0.50%)
Balkrishan Gill
Evelo Biosciences, Inc. - President, CEO & Director

Whilst everybody is getting comfortable, thank you, everybody, for joining us early morning. I wanted to make a few introductions and review the agenda first of all. So we're very pleased to have Dr. Lebwohl here, who will talk about the unmet need in psoriasis; Duncan McHale, our Chief Medical Officer, who will review the recent clinical data we presented, which is very exciting, in which, we've shown, for the first time, that our products and our biology lead to a clinical some response in psoriasis patients. So Duncan will review that. Also with us is David Epstein, our Chair, who, some of you'll probably know, David was the CEO of Novartis Pharmaceutical for many years, and very pleased to have recently appointed David as a...

So I wanted to begin with just framing what we are doing at Evelo. So the fundamental biology of Evelo is something I was just talking to Lilian about in terms of where we sit in the world of biotechnology today. So I've been in biotech for almost 35 years, I realized recently, and was involved in

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot